CXCR2 and neoplasm: Moreover, combining a CSF1R inhibitor with a CXCR2 inhibitor was shown to block granulocyte infiltration of tumors triggered by the inhibition of CSF1R and significantly reduce tumor growth (Kumar et al., 2017).